Sun Nov 23 00:16:54 SGT 2014  
SINGAPORE
GENITAL™
    Genital warts treatment, Singapore (SG)
HIV STD TESTING SINGAPORE™
Within 3 days after unprotected sex,
stop HIV infection with Post-Exposure Prophylaxis treatment
28 days after unprotected sex,
accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™

Summary

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening
Fri, 21 Nov 2014 20:25:19 +0100 | Journal of Medical Virology
With the introduction of Human papillomavirus (HPV) vaccination in young girls in 2007, it is important to monitor HPV infections and epidemiological changes in this target population. The present study has evaluated the detection of human papillomavirus DNA in paired cervical and urine samples to understand if HPV testing in urine could be used as non‐invasive method to monitor HPV status in young women. The study enrolled 216 twenty five‐year‐old women, resident in Florence and invited for the first time to the cervical cancer Screening Program within a project evaluating the impact of HPV vaccination. HPV genotyping was performed on 216 paired urine and cervical samples. The overall concordance between cervix and urine samples, investigated by HPV genotyping (INNO‐LiPA HPV Genot...

Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma
Fri, 21 Nov 2014 00:00:00 +0100 | Tumor Biology
Conclusion

p16INK4 Expression is not associated with human papillomavirus in oral lichen planus
Fri, 21 Nov 2014 00:00:00 +0100 | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Conclusions p16INK4 overexpression is not correlated with HPV in patients with LP. (Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology)

Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
Thu, 20 Nov 2014 18:25:04 +0100 | Acta Oto-Laryngologica
Conclusion: Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) is considered to be a distinct entity in Japan. The combination of both HPV-DNA sequencing analysis and immunohistochemistry (IHC) for p16(INK4A) is useful to discriminate the OPSCC patients with a better prognosis from other cases, especially in the advanced stage. Surgical treatment is recommended for HPV-negative advanced cancer.

Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998–2007
Thu, 20 Nov 2014 00:00:00 +0100 | Spatial and Spatio-temporal Epidemiology
This study analyzed the spatial dependence and pattern of HPV-associated cancers in Minnesota from 1998 to 2007 using sparse spatial generalized linear mixed models and scan statistics for cluster detection. A strong clustering pattern was seen in the northern region of Minnesota for both men and women. Separate cluster analyses by gender identified areas of overlapping disease burden. The patterns observed in this analysis demonstrate the need to account for spatial dependence when analyzing disease rates for geographic areas (i.e. county or ZIP codes) since spatial analyses of HPV-associated cancers have the potential to identify areas with the highest HPV disease burden and may serve to uncover areas where policies and HPV vaccination strategies can be most beneficial. (Source: Spatial ...

Concurrence of Multiple Human Papillomavirus Infections in a Large US Population-based Cohort
Thu, 20 Nov 2014 00:00:00 +0100 | American Journal of Epidemiology
We examined the concurrence of multiple human papillomavirus (HPV) infections in 47,617 women who underwent cervical screening in New Mexico between December 2007 and April 2009 using the LINEAR ARRAY HPV Genotyping Test (Roche Diagnostics, Indianapolis, Indiana), which detects 37 different types of HPV. Our primary goal was to examine the distributions of multiple HPV types with a special interest in negative interactions, which could signal the possibility of type replacement associated with a common niche if some HPV types were prevented by vaccination. Multiple infections were found to be more common than expected under independence, but this could largely be accounted for by a woman-specific latent heterogeneity parameter which was found to be dependent on age and cytological grade. W...

Invited Commentary: Multiple Human Papillomavirus Infections and Type Replacement--Anticipating the Future After Human Papillomavirus Vaccination
Thu, 20 Nov 2014 00:00:00 +0100 | American Journal of Epidemiology
Prophylactic human papillomavirus (HPV) vaccination with 3 doses of either of 2 commercially available vaccines is highly efficacious in preventing infections with the most carcinogenic types of HPV (HPV 16 and HPV 18) at the cervix and other anatomical sites at which HPV-related cancers develop. Concern has been raised that eradicating the most virulent HPV types, 16 and 18, could result in 1 or more of the types that are not targeted by the vaccine occupying the ecological niche created by the elimination of these types, referred to as type replacement. In this issue of the Journal, Yang et al. (Am J Epidemiol. 2014;180(11):1066–1075) report on concurrent infections with multiple HPV types in unvaccinated women who underwent cervical screening in New Mexico (December 2007–Apr...

Comments on HPV and lung cancer risk: a meta-analysis, authors Zhai et al., Journal of Clinical Virology 2014 (in press)
Thu, 20 Nov 2014 00:00:00 +0100 | Journal of Clinical Virology
This current issue of the Journal of Clinical Virology includes a report by Zhai et al. on the results of a meta-analysis (MA) which concluded that human papillomavirus (HPV) infection increases the risk of lung cancer (LC) [1]. If confirmed, this concept would have a major impact on our understanding of the pathogenesis of LC and could be used to support the view that HPV testing should be implemented to screen for LC and that vaccination for HPV could decrease LC incidence and fatalities. (Source: Journal of Clinical Virology)

Supporting Local Health Departments (LHDs) to Increase Human Papillomavirus (HPV) Vaccination Rates Request For Applications (RFA) Applications are due December 19, 2014 at 5:00pm EST
Wed, 19 Nov 2014 16:00:57 +0100 | PHPartners.org
A webinar to answer questions about the funding opportunity and application process will be held on November 24, 2014 at 2:00 PM EST. (Source: PHPartners.org)

Kissing and hpv: honest popular visions, the human papilloma virus, and cancers.
Wed, 19 Nov 2014 05:08:29 +0100 | Current Oncology
Authors: Touyz LZ